Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
IRVINE, Calif., Aug. 17, 2017 -- MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”), today announced that Frank Grillo, CEO, will present at the 2017 Southern California Investor Conference (“SCIC”) on Thursday, August 24, 2017, at 10:00 a.m. Pacific Time. The event will be held at the Island Hotel in Newport Beach, California.
Management will be available to meet with investors throughout the day. Investors wishing to schedule a meeting may do so through the SCIC website, http://www.scic2017.com, or by contacting MRI Interventions’ Investor Relations at [email protected].
A live webcast of the presentation will be provided by the conference through its website at http://www.scic2017.com.
About MRI Interventions, Inc.
Building on the imaging power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Forward-Looking Statements
Statements herein concerning the Company’s plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: future revenues from sales of the Company’s ClearPoint Neuro Navigation System products; the Company’s ability to market, commercialize and achieve broader market acceptance for the Company’s ClearPoint Neuro Navigation System products; and estimates regarding the sufficiency of the Company’s cash resources. More detailed information on these and additional factors that could affect the Company’s actual results are described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2017, both of which have been filed with the Securities and Exchange Commission.
Contact Information: Matt Kreps, Darrow Associates Investor Relations Phone: (214) 597-8200 Email: [email protected]
